At Suraksha, we specialize in advanced genomic testing, ensuring safe and accurate results for expectant parents. Our team, led by a cytogeneticist with over 30 years of experience, is dedicated to providing reliable insights into prenatal health.
Read moreOur Services
Our advanced genetic testing services provide crucial insights into fetal health. Trust our expertise to guide you through every step of the process.
Microarray testing is a powerful, high-resolution genetic analysis that examines your DNA with unprecedented precision. Unlike traditional chromosome testing (karyotyping), microarray detects even the smallest missing or extra pieces of genetic material called CNVs.
Know More
Quantitative Fluorescent Polymerase Chain Reaction (QF-PCR) is an advanced molecular diagnostic test that provides rapid detection of common chromosomal aneuploidies - specifically chromosomes 13, 18, 21, X and Y.
Know More
Fluorescence In Situ Hybridization (FISH) is a sophisticated cytogenetic technique that allows direct visualization of specific chromosomes using fluorescent DNA probes. This powerful diagnostic method precisely identifies the presence, number of chromosomes.
Know More
Karyotyping is the cornerstone of cytogenetic analysis - a powerful technique that examines the complete set of chromosomes in a cell. This gold-standard method creates a detailed chromosomal "portrait," revealing the number, size, shape, and banding pattern.
Know More
Non-Invasive Prenatal Testing (NIPT) represents a revolutionary advancement in prenatal screening that analyzes cell-free DNA (cfDNA) circulating in a pregnant woman's bloodstream. This cutting-edge technology examines genetic material.
Know More
Onco-genomics
Our FISH (Fluorescence In Situ Hybridization) services provide precise chromosomal analysis for cancer diagnostics and treatment planning. We offer a comprehensive range of probes for solid tumors and hematologic malignancies, including HER2/neu, ALK, BCR-ABL1, MYC, and more. FISH is critical for identifying gene rearrangements, amplifications, and deletions that guide targeted therapy decisions.
Our Solid Tumor NGS Panels are designed to detect clinically actionable mutations across a broad spectrum of cancer-related genes. These panels cover hotspots, full exons, and relevant structural variants in genes such as EGFR, KRAS, BRAF, TP53, and PIK3CA. Results support personalized therapy selection, clinical trial eligibility, and prognosis assessment. High-depth sequencing and advanced bioinformatics ensure sensitive and reliable mutation detection.
Our Hematologic Malignancy NGS Panels deliver detailed genetic profiling for leukemias, lymphomas, and myeloproliferative disorders. These panels target key mutations including NPM1, FLT3, CEBPA, JAK2, CALR, and others relevant to diagnosis, risk stratification, and therapeutic guidance.
Our Liquid Biopsy Panels enable non-invasive detection of tumor-derived mutations using circulating tumor DNA (ctDNA) from blood samples. This technology supports cancer monitoring, early detection of resistance mutations, and real-time assessment of treatment response. Our panels target key genes across multiple tumor types, offering an alternative when tissue biopsy is not feasible.
Paediatric Genetics
Conventional karyotyping is used to detect large chromosomal abnormalities such as aneuploidies, translocations, deletions, and duplications. It remains a key diagnostic tool for conditions like Down syndrome, Turner syndrome, and various structural rearrangements. This technique provides a full view of the chromosome structure at the metaphase level. All findings are reviewed and reported by board-certified cytogeneticists.
Chromosomal Microarray offers high-resolution genome-wide analysis to detect sub-microscopic copy number variations (CNVs) that are often missed by karyotyping. It is the first-tier test for children with developmental delay, intellectual disability, autism spectrum disorder, and multiple congenital anomalies. It identifies gains and losses of DNA segments that may be clinically significant.
For suspected monogenic disorders, we offer single-gene testing and targeted NGS panels focused on specific phenotypes or syndromes. These include epilepsy panels, skeletal dysplasia panels, neurodevelopmental disorder panels, and more. Each panel is curated for high-yield diagnostic value and includes full gene coverage with CNV detection where applicable.
Whole Exome Sequencing provides comprehensive analysis of all protein-coding regions in the genome, which are responsible for the majority of disease-causing mutations. It is particularly effective in diagnosing complex or rare genetic conditions when previous tests have been inconclusive. WES is often performed as a trio with parental samples to improve diagnostic accuracy and clarify inheritance patterns. All variants are assessed using advanced bioinformatics pipelines and interpreted according to ACMG guidelines.
Why Choose us?
Navigating the world of genetic testing can feel complex. At Suraksha, an NABL and CAP accredited laboratory, we simplify the process, providing clear insights and unwavering support based on internationally recognized quality standards.
Read more
Our specialists are here to assist you with prenatal genetic testing.